Science and Enterprise

Tag: Asia

  • North Africa, Middle East Entrepreneurial Programs Unveiled

    Two new programs aimed at spurring innovation based on science and technology in North Africa, Middle East, and South Asia were  unveiled at a kick-off meeting in Rabat, Morocco last week. The Civilian Research and Development Foundation (CRDF) in Arlington, Virginia manages the programs, with funding from the U.S. Department of State. One of new…

  • U.S. Patent Office Signs New, Expanded Reciprocity Deals

    The U.S. Patent and Trademark Office announced new or expanded patent reciprocity agreements with Israel, Korea, and the Nordic Patent Institute that covers Denmark, Norway, and Iceland. All of the agreements involve pilot tests of expedited patent examinations between the U.S. and partner countries. USPTO calls the overall reciprocity program the Patent Prosecution Highway (PPH).…

  • International Consortium Sequences Wheat Pathogen Genome

    A group of agricultural scientists has sequenced the genome of a pathogen that causes the wheat disease septoria tritici blotch, responsible for severe crop losses. Their findings appeared 9 June 2011 in the journal PLoS Genetics. The consortium, led by USDA plant pathologist Steven Goodwin included researchers from the U.S., Australia, Brazil, France, Germany, Iran,…

  • U.S. Cosmetics Company Opens China R&D Center

    Estée Lauder Companies Inc. in New York (ELC) is opening its Asia Innovation Center in Shanghai, China. The new center expands on the company’s research lab that opened in China in 2005. ELC has been doing business in China since 1993. The company says the center will help develop products tailored to the needs of…

  • Study Highlights Crop Regions At Risk from Climate Change

    A study by the Consultative Group on International Agricultural Research (CGIAR) identifies food production regions in the world most at risk from disruption due to climate change. Some of these populations, in Africa and South Asia for example, are already facing food shortages, while other food-producing regions including China and Latin America run the risk…

  • Solvay to Form Research Center at Korean Women’s University

    Solvay, a chemical company in Brussels, Belgium, says it will locate its Korean research center on the campus of EWHA Women’s University in Seoul. The company’s investment in this venture will total EUR 16.8 million (USD 24.0 million). Solvay plans to invest EUR 13 million in a Research, Development and Technology (RDT) Centre at EWHA.…

  • Non-Narcotic Natural Pain Killer Synthesized

    Scientists from the Scripps Research Institute in Jupiter, Florida have synthesized a rare natural product isolated from the bark of a plant widely used in traditional medicine, that has potential as a non-narcotic pain killer. Their findings appear online in the journal Nature Chemistry (paid subscription required). The study defined a way to generate quantities…

  • Interactive Map Shows Off-Grid Energy Technology Sites

    Santa Clara University in California and social-enterprise information company Ayllu have created the Energy Map Web site that offers graphs and analyses of 40 social enterprises in 16 countries that bring electricity or alternative fuel to communities of 500 to 500,000 people each. All 40 of the sites involve energy produced or consumed outside of…

  • Nanotech Patch Repairs Damaged Heart Tissue in Lab Tests

    Engineers at Brown University in Providence, Rhode Island and India Institute of Technology (IIT) in Kanpur created a patch made from carbon nanofibers and a polymer material that restores damaged cardiac tissue similar to the damage resulting from a heart attack.  The team reported their results online earlier this month in the journal Acta Biomaterialia…

  • Sanofi, Glenmark Sign Autoimmune Antibody License Deal

    The French pharmaceutical company Sanofi and Glenmark Pharmaceuticals Ltd. in Mumbai, India have signed an agreement for development and commercialization of GBR500, a monoclonal antibody to treat chronic autoimmune disorders. The deal is expected to close  next month following required regulatory steps. GBR500, developed by Glenmark, targets receptors that affect the adhesion of lymphocytes (white…